RxDoctor Payments Data

Alison Boyce

Pediatric Endocrinology · Washington, DCNPI 1326209388

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $6,010 of the $6,484 with a category attached, or 92.7%. Ultragenyx Pharmaceutical Inc. accounts for 95.1% of it on its own, with 1 other manufacturer making up the rest.

$6,484in general payments, 2019–2025

Across 3 payments — averaging $2161.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ultragenyx Pharmaceutical Inc.$6K
  • AstraZeneca$321
$634,140in research payments, 2019–2025

Across 5 payments — averaging $126,828 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$634K

What the payments were for

  • Travel & lodging$6,01093%
  • Food & beverage$4747%

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Ultragenyx Pharmaceutical Inc.2$6,163
AstraZeneca1$321

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,484 in reported general payments places this provider in the 55th percentile of 20 pediatric endocrinology providers in District of Columbia.

See all pediatric endocrinology providers in District of Columbia

Other pediatric endocrinology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →